Re-Irradiation of Recurrent Nasopharyngeal Cancer: A 4-year Follow-up Study of Treatment using 3-Dimensional Conformal Radiotherapy

Samuel Kelvin Ruslim, Selviant Selviant, Aviciena Bin Iskandar, Sielvyana Sie, A. Hariyanto, Monika Kencana Dewi
{"title":"Re-Irradiation of Recurrent Nasopharyngeal Cancer: A 4-year Follow-up Study of Treatment using 3-Dimensional Conformal Radiotherapy","authors":"Samuel Kelvin Ruslim, Selviant Selviant, Aviciena Bin Iskandar, Sielvyana Sie, A. Hariyanto, Monika Kencana Dewi","doi":"10.33371/ijoc.v16i1.837","DOIUrl":null,"url":null,"abstract":"Introduction: Nasopharyngeal cancer (NPC) is a prevalent diagnosis of head and neck cancers (HNC) in Asia. In Indonesia, it is estimated that there are 12,000 new cases per year. Case Presentation: The author reports a 25-year-old male patient with recurrent NPC. This patient was first diagnosed with NPC stage IVB in 2013 and was treated by chemoradiation. In 2016, he found another mass in his neck. The biopsy result showed the recurrence of the NPC with histopathology of Undifferentiated carcinoma (WHO type III). Re-irradiation was planned, and the patient subsequently received 3D-Conformal Radiotherapy (3D-CRT) at our department. Four years after the completion of re-irradiation, the patient was alive and well with no signs of recurrence but still complained about late toxicities like trismus and fibrotic neck.  Conclusions: In this study, we discuss the use of 3D-CRT in the re-irradiation of NPC with its limitation on obtaining optimum dose sculpture compared to more sophisticated and widely spread modalities like intensity-modulated radiotherapy (IMRT). However, with careful planning, we can still obtain optimum tumor dose, minimize organs at-risk (OAR) dose, and subsequently late toxicities that come after. We hope that this study can bring hope to centers with limited facilities, and we suggest further studies on re-irradiation, especially in OAR dose tolerance guidelines.","PeriodicalId":13489,"journal":{"name":"Indonesian Journal of Cancer","volume":"116 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indonesian Journal of Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33371/ijoc.v16i1.837","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Nasopharyngeal cancer (NPC) is a prevalent diagnosis of head and neck cancers (HNC) in Asia. In Indonesia, it is estimated that there are 12,000 new cases per year. Case Presentation: The author reports a 25-year-old male patient with recurrent NPC. This patient was first diagnosed with NPC stage IVB in 2013 and was treated by chemoradiation. In 2016, he found another mass in his neck. The biopsy result showed the recurrence of the NPC with histopathology of Undifferentiated carcinoma (WHO type III). Re-irradiation was planned, and the patient subsequently received 3D-Conformal Radiotherapy (3D-CRT) at our department. Four years after the completion of re-irradiation, the patient was alive and well with no signs of recurrence but still complained about late toxicities like trismus and fibrotic neck.  Conclusions: In this study, we discuss the use of 3D-CRT in the re-irradiation of NPC with its limitation on obtaining optimum dose sculpture compared to more sophisticated and widely spread modalities like intensity-modulated radiotherapy (IMRT). However, with careful planning, we can still obtain optimum tumor dose, minimize organs at-risk (OAR) dose, and subsequently late toxicities that come after. We hope that this study can bring hope to centers with limited facilities, and we suggest further studies on re-irradiation, especially in OAR dose tolerance guidelines.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
复发鼻咽癌的再照射:三维适形放疗治疗的4年随访研究
简介:鼻咽癌(NPC)是亚洲头颈癌(HNC)的常见诊断。在印度尼西亚,估计每年有1.2万例新病例。病例介绍:作者报告一位25岁男性复发性鼻咽癌患者。该患者于2013年首次被诊断为鼻咽癌IVB期,并接受了放化疗。2016年,他在脖子上发现了另一个肿块。活检结果显示鼻咽癌复发,组织病理学为未分化癌(WHO III型)。计划再次照射,患者随后在我科接受3d适形放疗(3D-CRT)。再照射完成4年后,患者存活良好,无复发迹象,但仍抱怨晚期毒性,如牙关紧闭和纤维化颈部。结论:在本研究中,我们讨论了3D-CRT在鼻咽癌再照射中的应用,与更复杂和广泛传播的调强放疗(IMRT)等方式相比,它在获得最佳剂量分割方面的局限性。然而,通过仔细的计划,我们仍然可以获得最佳的肿瘤剂量,最小化器官危险(OAR)剂量,以及随后出现的晚期毒性。我们希望这项研究能给设施有限的中心带来希望,我们建议进一步研究再照射,特别是在OAR剂量耐受指南中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The Role of Isocitrate Dehydrogenase as a Serum Biomarker in Detecting Non-Small Cell Lung Cancer: A Literature Review Impact of Artificial Intelligence on Mammography Interpretation by Breast Radiologists, Non-Breast Radiologists, and Senior Residents Factors Influencing Distress and Coping Strategies Among Patients with Metastatic Spinal Tumor at Cipto Mangunkusumo General Hospital Major Microbiota Profile of Breast Cancer From Faecal Specimen and Cancerous Breast Tissue: A Comprehensive Systematic Review Recent Technological Advancements in Respiratory Gating Devices
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1